✦ LIBER ✦

Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy

✍ Scribed by Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Tetsuya Toge

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 143 KB
Volume: 101
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20696

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical evaluation of antisense bcl-

Preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma

✍ Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Tetsuya Toge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

Development of a hammerhead ribozyme aga

Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer

✍ Dorai, Thambi; Olsson, Carl A.; Katz, Aaron E.; Buttyan, Ralph 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

## Background: The bcl-2 oncoprotein suppresses apoptosis and, when overexpressed in prostate cancer cells, makes these cells resistant to a variety of therapeutic agents, including hormonal ablation. therefore, bcl-2 provides a strategic target for the development of gene knockout therapies to tre

ChemInform Abstract: Synthesis and Evalu

ChemInform Abstract: Synthesis and Evaluation of Novel N-Substituted-6-methoxynaphthalene-2-carboxamides as Potential Chemosensitizing Agents for Cancer.

✍ Tushar Narendra Lokhande; Chelakara Lakshmann Viswanathan; Aarti Shashikant Juve 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 26 KB 👁 1 views

Potential role of bcl-2 as a suppressor

Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer

✍ Michael I. Koukourakis; Alexandra Giatromanolaki; Kenneth J. O'Byrne; Ruth M. Wh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 231 KB 👁 2 views

It has been reported that genes regulating apoptosis may play a role in tumoral angiogenesis. This study examined the relationship between tumour vascularization, a measure of tumour angiogenesis, and bcl-2 and p53 expression in operable non-small-cell lung cancer (NSCLC). The relationship between b

Parathyroid hormone-related protein as a

Parathyroid hormone-related protein as a potential target of therapy for cancer-associated morbidity

✍ Etsuro Ogata 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

Cytosine deaminase gene as a potential t

Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer

✍ Rowley, Simon; Lindauer, Marcus; Gebert, Johannes F.; Haberkorn, Uwe; Oberdorfer 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

The bacterial enzyme cytosine deaminase (CD) catalyzes the conversion of 5-fluorocytosine (5-FC) to the lethal 5-fluorouracil (5-Fu) and so provides a useful system for selective killing of gene-modified mammalian tumor cells. Cloning of the CD gene from Escherichiu coli and expression in human tumo